Description
IGF-1 LR3 (Insulin-like Growth Factor-1 Long R3) is a synthetic analog of the naturally occurring IGF-1, a hormone that plays a crucial role in growth and development. IGF-1 LR3 is modified to enhance its stability and prolong its half-life in the bloodstream, making it more effective for therapeutic and research purposes. This peptide consists of 83 amino acids and is known for its ability to promote cell growth, proliferation, and differentiation. IGF-1 LR3 is typically available in a lyophilized powder form, which requires reconstitution with an appropriate solvent prior to use, usually included in the packaging. Its mechanism of action involves binding to the IGF-1 receptor, which activates various signaling pathways that contribute to anabolic processes in the body.
Medical use
IGF-1 LR3 is primarily used in research and clinical settings for its potential anabolic effects. It is known to promote muscle growth and repair, making it of interest in the fields of sports medicine and bodybuilding. The peptide can enhance protein synthesis, increase muscle mass, and improve recovery from injuries.
In addition to its applications in muscle growth, IGF-1 LR3 has been studied for its potential benefits in various medical conditions, including growth hormone deficiencies and certain metabolic disorders. It may also play a role in improving insulin sensitivity and glucose metabolism, which can be beneficial for individuals with insulin resistance or type 2 diabetes.
